paper human control brain biopsies amsbio (AMS Biotechnology)
93
Structured Review
AMS Biotechnology
paper human control brain biopsies amsbio
Paper Human Control Brain Biopsies Amsbio, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+brain+controls/Brain%2C+cerebral+cortex-Normal+OCT+frozen+tissue/pm38537685-232-23-28
Average 93 stars, based on 1 article reviews
Paper Human Control Brain Biopsies Amsbio, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+brain+controls/Brain%2C+cerebral+cortex-Normal+OCT+frozen+tissue/pm38537685-232-23-28
Average 93 stars, based on 1 article reviews
paper human control brain biopsies amsbio - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Recombinant:Article Title: KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation. Article Snippet: In brief Arce et al. show that KRIT1 heterozygous mutations drive cavernoma-like structures in vascularized organoids and alter endothelial cell-cell junctions.. KRIT1-deficient vascular cells reshaped brain vasculature through extracellular matrix organization, proliferation, and mesenchymal transition.. The endothelial progenitor marker PEG3 was highly expressed in CCM patient-derived endothelial cells and patient cavernoma biopsies. Transfection:Article Title: KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation. Article Snippet: In brief Arce et al. show that KRIT1 heterozygous mutations drive cavernoma-like structures in vascularized organoids and alter endothelial cell-cell junctions.. KRIT1-deficient vascular cells reshaped brain vasculature through extracellular matrix organization, proliferation, and mesenchymal transition.. The endothelial progenitor marker PEG3 was highly expressed in CCM patient-derived endothelial cells and patient cavernoma biopsies. Membrane:Article Title: KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation. Article Snippet: In brief Arce et al. show that KRIT1 heterozygous mutations drive cavernoma-like structures in vascularized organoids and alter endothelial cell-cell junctions.. KRIT1-deficient vascular cells reshaped brain vasculature through extracellular matrix organization, proliferation, and mesenchymal transition.. The endothelial progenitor marker PEG3 was highly expressed in CCM patient-derived endothelial cells and patient cavernoma biopsies. Clinical Proteomics:Article Title: KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation. Article Snippet: In brief Arce et al. show that KRIT1 heterozygous mutations drive cavernoma-like structures in vascularized organoids and alter endothelial cell-cell junctions.. KRIT1-deficient vascular cells reshaped brain vasculature through extracellular matrix organization, proliferation, and mesenchymal transition.. The endothelial progenitor marker PEG3 was highly expressed in CCM patient-derived endothelial cells and patient cavernoma biopsies. Functional Assay:Article Title: KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation. Article Snippet: In brief Arce et al. show that KRIT1 heterozygous mutations drive cavernoma-like structures in vascularized organoids and alter endothelial cell-cell junctions.. KRIT1-deficient vascular cells reshaped brain vasculature through extracellular matrix organization, proliferation, and mesenchymal transition.. The endothelial progenitor marker PEG3 was highly expressed in CCM patient-derived endothelial cells and patient cavernoma biopsies. RNA sequencing:Article Title: KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation. Article Snippet: In brief Arce et al. show that KRIT1 heterozygous mutations drive cavernoma-like structures in vascularized organoids and alter endothelial cell-cell junctions.. KRIT1-deficient vascular cells reshaped brain vasculature through extracellular matrix organization, proliferation, and mesenchymal transition.. The endothelial progenitor marker PEG3 was highly expressed in CCM patient-derived endothelial cells and patient cavernoma biopsies. Control:Article Title: Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology. Article Snippet: Background: Cerebral cavernous malformation (CCM) is a disease associated with an elevated risk of focal neurological deficits, seizures, and hemorrhagic stroke.. The disease has an inflammatory profile and improved knowledge of CCM pathology mechanisms and exploration of candidate biomarkers will enable new non-invasive treatments.. Methods: We analyzed protein signatures in human CCM tissue samples by using a highly specific and sensitive multiplexing technique, proximity extension assay. |